Business

As the Thanksgiving holiday approaches, airlines are gearing up for what is expected to be a record-breaking travel season. The Transportation Security Administration (TSA) is projecting that they will screen approximately 30 million passengers from November 17th to November 28th, the highest number ever recorded. With an estimated 2.9 million passengers taking to the skies
0 Comments
Investment firm JAT Capital recently sent a strongly worded letter to the board of Bed Bath & Beyond, expressing their frustrations and concerns over the company’s behavior and lack of transparency. In the letter, JAT Capital accuses the board of refusing to answer questions from shareholders and engaging in what they describe as “poor behavior”.
0 Comments
Elon Musk’s aerospace company, SpaceX, has received clearance from the Federal Aviation Administration (FAA) to proceed with the second flight test of its Starship rocket. This announcement comes after the unfortunate explosion of the previous launch in April, which caused significant damage and raised environmental concerns. Despite this setback, the FAA has conducted a thorough
0 Comments
The United Auto Workers (UAW) recently reached a tentative agreement with General Motors (GM), but the ratification process has faced obstacles along the way. While initial voting results seemed promising, several large plants voted against the pact, causing uncertainty about its prospects. This article analyzes the challenges faced by the UAW and the implications of
0 Comments
In a bid to streamline operations and reduce costs, Stellantis, the parent company of Chrysler, has announced voluntary separation packages for approximately half of its U.S. white-collar employees. This move comes as the U.S. auto industry continues to face challenging market conditions and companies seek to allocate funds for emerging technologies, particularly electric vehicles. Stellantis’
0 Comments
Novo Nordisk’s groundbreaking drug, Wegovy, has shown tremendous potential in reducing the risk of serious cardiovascular complications in individuals with obesity and heart disease. In the highly anticipated Select study, which included approximately 17,500 participants without diabetes, Wegovy demonstrated a significant impact on heart attacks, signaling a new frontier for the drug. The comprehensive results
0 Comments